Table 3.
Factors influencing erectile dysfunction treatment instauration using univariate and multivariate analyses
| Factors | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| Odds ratio (95% CI) | P | Odds ratio (95% CI) | P | |
| Age | 1.013 (0.923–1.112) | 0.779 | 1.043 (0.937–1.162) | 0.438 |
| Pre-VTP IIEF5 score | 0.977 (0.920–1.037) | 0.436 | 0.976 (0.913–1.043) | 0.976 |
| Cancer progression | 0.587 (0.202–1.709) | 0.237 | 0.416 (0.129–1.338) | 0.141 |
| Repeated VTP | 0.234 (0.049–1.118) | 0.045 | 0.210 (0.037–1.189) | 0.078 |
| Bilateral treatment | 1.360 (0.484–3.826) | 0.371 | 1.301 (0.442–4.014) | 0.647 |
| Extraprostatic necrosis | 3.221 (1.235–8.401) | 0.014 | 3.657 (1.247–10.724) | 0.018 |
P<0.05 means statistically significant. CI: confidence interval; pre-VTP IIEF5 score: prevascular-targeted photodynamic International Index of Erectile Function score; repeated VTP: repeated vascular-targeted photodynamic; OR: odds ratio